A2a adenosine receptor agonists

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/52 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2317093

Agonists of A2A adenosine receptors in combination with rolipram, its derivatives or other Type IV phosphodiesterase (PDE) inhibitors are effective for the treatment of inflammatory diseases.

L'invention concerne des agonistes de récepteurs d'adénosine A¿2A? combinés avec du rolipram, leurs dérivés ou d'autres inhibiteurs de phosphodiestérase (PDE) type IV qui sont efficaces pour le traitement de maladies inflammatoires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

A2a adenosine receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with A2a adenosine receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and A2a adenosine receptor agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1801578

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.